Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin

Michiko Yamamoto, Akira Takakura, Noriyuki MasudaDepartment of Respiratory Medicine, Kitasato University School of Medicine, Kitasato, JapanAbstract: Amrubicin is a totally synthetic anthracycline anticancer agent that acts as a potent topoisomerase II inhibitor. Amrubicin has been approved in Japan...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Michiko Yamamoto (Auteur), Akira Takakura (Auteur), Noriyuki Masuda (Auteur)
Formaat: Boek
Gepubliceerd in: Dove Medical Press, 2008-09-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar